Temporal change in microdosimetry to bone marrow and stromal progenitor cells from alpha-particle-emitting radionuclides incorporated in bone.
Affiliation
CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, United Kingdom.Issue Date
1999-12
Metadata
Show full item recordAbstract
The microdistributions of the alpha-particle-emitting bone surface-seeking radionuclides (239)Pu, (241)Am and (233)U in the mouse femoral shaft have been studied using computer-based image analysis of neutron-induced and alpha-particle track autoradiographs, prepared from femora of CBA/H mice which had been injected with 40 kBq kg(-1) of radionuclide (as citrate solution) at times from 1 to 448 days previously. Employing dosimetric methods, radiation dose rates and cumulative radiation doses to regions of the bone marrow thought to contain hemopoietic and stromal progenitor cells susceptible to neoplastic transformation to leukemia and osteosarcomas have been calculated. It has been shown that the three radionuclides differ in their relative deposition on the bone surfaces, and that patterns of changing redistribution with time are also varied. For stromal progenitor cells, which are thought to be targets for induction of osteosarcoma and are found in proximity to the bone surfaces, cumulative doses showed the trend (239)Pu > (241)Am > (233)U, correlating well with incidences of osteosarcoma observed in mice. Cumulative doses to the primitive hemopoietic stem cells, concentrated in the central marrow and thought to be susceptible to neoplastic transformation to myeloid leukemia, were considerably lower and also showed the trend plutonium > americium > uranium.Citation
Temporal change in microdosimetry to bone marrow and stromal progenitor cells from alpha-particle-emitting radionuclides incorporated in bone. 1999, 152 (6 Suppl):S38-42 Radiat. Res.Journal
Radiation ResearchPubMed ID
10564934Type
ArticleLanguage
enISSN
0033-7587Collections
Related articles
- Tumorigenic target cell regions in bone marrow studied by localized dosimetry of 239Pu, 241Am and 233U in the mouse femur.
- Authors: Lord BI, Austin AL, Ellender M, Haines JW, Harrison JD
- Issue date: 2001 Jun
- Microdistribution and localized dosimetry of the alpha-emitting radionuclides 239Pu, 241Am and 233U in mouse femoral shaft.
- Authors: Austin AL, Ellender M, Haines JW, Harrison JD, Lord BI
- Issue date: 2000 Jan
- Alpha-particle doses to cells of the bone remodeling cycle from alpha-particle-emitting bone-seekers: indications of an antiresorptive effect of actinides.
- Authors: Salmon PL, Onischuk YN, Bondarenko OA, Lanyon LE
- Issue date: 1999 Dec
- Radiation dose to trabecular bone marrow stem cells from (3)H, (14)C and selected alpha-emitters incorporated in a bone remodeling compartment.
- Authors: Nie H, Richardson RB
- Issue date: 2009 Feb 21
- Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
- Authors: Harrison JD, Muirhead CR
- Issue date: 2003 Jan